In a recent study published in Science, Orecchioni et al. provide insights that olfactory receptor 2 (OLFR2) in vascular macrophages plays a substantial role during atherosclerosis formation, identifying an alternative target for the prevention and treatment of ASCVD.1 This evidence concerns the gene OR2H2 and atherosclerosis.